Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linjeta vs Humalog in Pumps for Type 1 Diabetes
NCT01067118Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- Apr 2010
- Primary completion
- Jan 2011
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of VIAject in type 1 diabetes mellitus (T1D), sponsored by Stanford University. Planned start Apr 2010; status: withdrawn.
02
Drugs
VIAject
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01067118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01067118.